Search

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Nanorobots developed by engineers from the UK and China have delivered precision treatment to brain aneurysms

Shifting trends demand a change in how pharma field reps interact with healthcare professionals

How Asahi Kasei Bioprocess is incorporating ergonomics into biopharma equipment to make manufacturing safer, more efficient, and more productive.

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

What’s going on with nitrosamines? Naiffer Romero from the USP walks us through frequently asked questions.

A campaign to vaccinate children against polio in Gaza has begun, but success will depend on the vital role of the pharmaceutical industry.

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.

This study highlights the benefits of incorporating Recombinant Insulin in hiPSC culture to enhance the quality and productivity of these cells